Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis
Open Access
- 1 February 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 40 (2) , 133-139
- https://doi.org/10.1093/rheumatology/40.2.133
Abstract
Objective. To analyse the distribution of predisposing DQ3 (DQB1*03(*04)/DQA1*03) and DQ5 (DQB1*0501/DQA1*01), shared epitope encoding and protective DRB1 alleles in patients with early rheumatoid arthritis (RA) and undifferentiated arthritis (UA). Methods. Consecutive patients enrolled in an early arthritis clinic were DNA‐typed for HLA‐DQ and DR. RA patients (n=195), UA patients (n=160) and controls from the same region (n=306) were sorted according to their DQ‐DR phenotypes: DQ3 vs DQ5 and the presence or absence of a protective DERAA‐positive DRB1 molecule. The three groups were also sorted according to the shared epitope (SE) hypothesis. Results. We observed the association of both DQ3 and DQ5 with RA. DQ3/3 homozygous individuals had the highest risk of developing disease [odds ratio (OR)=20.00]. Conversely DQ5, but not DQ3, was associated with undifferentiated arthritis (OR=2.15 vs 1.25). Consistent with these differences, DQ3‐positive individuals had significantly more active disease at the first visit at the outpatient clinic than DQ5‐positive patients. DRB1 alleles encoding a DERAA motif in their third hypervariable region provided a strong dominant protection against RA among DQ5‐positive individuals and decreased arthritis activity among DQ3‐positive patients. Individuals with SE‐positive DR1, DR4 and DR10 alleles were also predisposed to RA, DR4/4 homozygous individuals having the highest risk of developing RA (OR=11.00). Conclusion. The DQ3‐DR4/9 haplotypes are associated with RA. The DQ5‐DR1/10 haplotypes are associated with less active disease, i.e. UA, and DERAA encoding DRB1 alleles modulate either predisposition to or the severity of RA. We propose that HLA polymorphism influences not only the initiation or perpetuation of RA but also protection against the disease.Keywords
This publication has 24 references indexed in Scilit:
- Inhibition of allorecognition by a human class II MHC–derived peptide through the induction of apoptosisJournal of Clinical Investigation, 1999
- The Homozygote of HLA-DRB1*0901, not its Heterozygote, is Associated with Rheumatoid Arthritis in Japanese: SHORT REPORTScandinavian Journal of Rheumatology, 1998
- Invited anniversary review: HLA associated diseasesHuman Immunology, 1997
- HLA markers and prediction of clinical course and outcome in rheumatoid arthritisArthritis & Rheumatism, 1997
- Presentation of self peptides by dendritic cells. Possible implications for the pathogenesis of rheumatoid arthritisArthritis & Rheumatism, 1996
- Could HLA-DRB1 be the protective locus in rheumatoid arthritis?Immunology Today, 1995
- Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community.Annals of the Rheumatic Diseases, 1993
- Novel genetic markers of rheumatoid arthritis in chilean patients, by dr serotyping and restriction fragment length polymorphism analysisArthritis & Rheumatism, 1992
- Dwl4(DRBl*0404) is a Dw4‐dependent risk factor for rheumatoid arthritis Rethinking the “shared epitope” hypothesisTissue Antigens, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988